DOP2010000250A - Procedimiento de preparacion de combretastatina - Google Patents

Procedimiento de preparacion de combretastatina

Info

Publication number
DOP2010000250A
DOP2010000250A DO2010000250A DO2010000250A DOP2010000250A DO P2010000250 A DOP2010000250 A DO P2010000250A DO 2010000250 A DO2010000250 A DO 2010000250A DO 2010000250 A DO2010000250 A DO 2010000250A DO P2010000250 A DOP2010000250 A DO P2010000250A
Authority
DO
Dominican Republic
Prior art keywords
formula
salt
base
compound
combretastatin
Prior art date
Application number
DO2010000250A
Other languages
English (en)
Inventor
Marc Frederic
Sylviane Lutz
Joel Malpart
Philippe Masson
Stephane Mutti
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39816950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2010000250(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of DOP2010000250A publication Critical patent/DOP2010000250A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

La invención se refiere a un procedimiento de preparación de una combretastatina (A): fórmula (l) en forma de base o de una sal de adición con un ácido, que consiste en acoplar en presencia de una base y de T3P la sal del compuesto (Z)-amino de fórmula (II) con un derivado de la L- serina doblemente protegido de fórmula (III) en la cual PG designa un grupo protector de la función amina de manera que se obtiene el compuesto de fórmula (Z)-(lb):fórmula (IV) luego, en desproteger y abrir el ciclo de (Z)-(lb) en presencia de un ácido de manera que se obtiene la combretastatina (A) en forma de sal; y, eventualmente, en añadir una base de manera que se obtiene la combretastatina (A) en forma de base, habiendo sido obtenida la sal del compuesto (Z)-amino mediante un enriquecimiento de la sal del compuesto amino de fórmula en isómero (Z).
DO2010000250A 2008-02-28 2010-08-12 Procedimiento de preparacion de combretastatina DOP2010000250A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0801092A FR2928148B1 (fr) 2008-02-28 2008-02-28 Procede de preparation de combretastatine

Publications (1)

Publication Number Publication Date
DOP2010000250A true DOP2010000250A (es) 2010-09-30

Family

ID=39816950

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2010000250A DOP2010000250A (es) 2008-02-28 2010-08-12 Procedimiento de preparacion de combretastatina

Country Status (28)

Country Link
US (1) US20110124899A1 (es)
EP (2) EP2252572A1 (es)
JP (1) JP2011513286A (es)
KR (1) KR20100116644A (es)
CN (1) CN102015620A (es)
AR (1) AR072772A1 (es)
AU (1) AU2009229027A1 (es)
BR (1) BRPI0907999A2 (es)
CA (1) CA2716541A1 (es)
CL (3) CL2009000463A1 (es)
CO (1) CO6241150A2 (es)
CR (1) CR11635A (es)
DO (1) DOP2010000250A (es)
EA (2) EA201300249A1 (es)
EC (1) ECSP10010421A (es)
FR (1) FR2928148B1 (es)
HN (1) HN2010001700A (es)
IL (2) IL207754A0 (es)
MA (1) MA32193B1 (es)
MX (1) MX2010009514A (es)
NI (1) NI201000144A (es)
NZ (1) NZ587505A (es)
PE (1) PE20091559A1 (es)
SG (1) SG183658A1 (es)
TW (1) TW200948753A (es)
UY (1) UY31681A1 (es)
WO (1) WO2009118474A1 (es)
ZA (1) ZA201006137B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
CN104447598B (zh) * 2013-09-18 2017-09-22 浙江大德药业集团有限公司 Ca‑4的大环多胺衍生物及其抗肿瘤特性
CN104817519B (zh) * 2015-05-11 2016-11-16 中国药科大学 一类ca-4的衍生物、其制法及其医药用途
CN104892668B (zh) * 2015-05-12 2017-03-29 上海大学 考布他汀类似物水溶性前‑前药及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1217500A (en) * 1967-05-24 1970-12-31 Ici Ltd Separation of trans-trans enriched salts of 4,4'-diaminodicyclohexylmethane
US5731353A (en) 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5561122A (en) 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JPH08272028A (ja) * 1995-03-30 1996-10-18 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその製造方法
JP2000239274A (ja) * 1998-12-16 2000-09-05 Nippon Kayaku Co Ltd 新規ナフチリジン誘導体の製造法
PT1248605E (pt) * 1999-12-21 2007-03-30 Teva Pharma Novos polimorfos de cloridrato de sertralina, processos para a sua preparação, composições que os contêm e métodos para a sua utilização
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US6759555B2 (en) * 2002-04-11 2004-07-06 Aventis Pharma S.A. Process for the preparation of combretastatins
DE10333042B4 (de) * 2003-07-21 2005-09-29 Clariant Gmbh Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung

Also Published As

Publication number Publication date
EA201300249A1 (ru) 2013-08-30
EP2252572A1 (fr) 2010-11-24
CO6241150A2 (es) 2011-01-20
NZ587505A (en) 2012-06-29
SG183658A1 (en) 2012-09-27
IL207754A0 (en) 2010-12-30
PE20091559A1 (es) 2009-10-30
WO2009118474A8 (fr) 2010-09-10
UY31681A1 (es) 2009-09-30
KR20100116644A (ko) 2010-11-01
AR072772A1 (es) 2010-09-22
ZA201006137B (en) 2011-11-30
CL2012001742A1 (es) 2012-11-16
IL225776A0 (en) 2013-06-27
ECSP10010421A (es) 2010-09-30
MX2010009514A (es) 2010-12-15
CL2012001744A1 (es) 2012-10-12
US20110124899A1 (en) 2011-05-26
MA32193B1 (fr) 2011-04-01
FR2928148A1 (fr) 2009-09-04
JP2011513286A (ja) 2011-04-28
FR2928148B1 (fr) 2013-01-18
CR11635A (es) 2011-02-04
NI201000144A (es) 2011-03-09
CN102015620A (zh) 2011-04-13
BRPI0907999A2 (pt) 2019-01-15
CL2009000463A1 (es) 2010-12-03
TW200948753A (en) 2009-12-01
AU2009229027A1 (en) 2009-10-01
EA201071001A1 (ru) 2011-02-28
HN2010001700A (es) 2013-06-17
EP2562154A1 (fr) 2013-02-27
CA2716541A1 (fr) 2009-10-01
WO2009118474A1 (fr) 2009-10-01

Similar Documents

Publication Publication Date Title
DOP2010000250A (es) Procedimiento de preparacion de combretastatina
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
AR077701A1 (es) Compuestos antiproliferativos, conjugados de los mismos, procedimientos para estos, y usos de los mismos
UY32142A (es) Preparación de una quinoliniloxidifenilciclopropanodicarboxamida
NI201100223A (es) Derivados de imidazolidina 2 -0ne 1,3 - disustituidos como inhibidores de cyp 17
BR112014009146A8 (pt) formulações de etanercepte estabilizadas com aminoácidos
CR20140301A (es) Derivados de betulina
CO6210751A2 (es) Derivados de indolinona y procedimiento para su fabricacion
BR112012019762A2 (pt) composto, composição, e, método para tratar uma doença.
CR20150663A (es) Derivados de diazacarbazol como ligandos de tau para pet
BRPI0905147A8 (pt) processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
BR122018074306B8 (pt) Método para preparar um composto de fórmula 1a
BRPI1009212B8 (pt) Composto de piperazina capaz de inibir a prostaglandina d sintase, seus usos e composição farmacêutica
BR112015015368A2 (pt) composições de absorventes de dejetos de animais revestidas debaixa densidade
AR074545A1 (es) Proceso de preparacion de dihidroetorfina
BR112013008675A2 (pt) métodos e composições para o tratamento de diabetes e dislipidemia
BR112014004523A2 (pt) composto e composição aromatizante
MY165487A (en) Process for preparing a polyol ether
SV2008002512A (es) Derivados de aminoacidos ref. pc32769a
EA201490360A1 (ru) Композиции, содержащие соли аминокислот
BR112016018594B8 (pt) Método para produção do derivado de 2-aciliminopiridina
AR066054A1 (es) Proceso para preparar galantamina
BR112013001862A2 (pt) formulações
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης